1. Home
  2. FGEN vs GLBS Comparison

FGEN vs GLBS Comparison

Compare FGEN & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • GLBS
  • Stock Information
  • Founded
  • FGEN 1993
  • GLBS 2006
  • Country
  • FGEN United States
  • GLBS Greece
  • Employees
  • FGEN N/A
  • GLBS N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • GLBS Marine Transportation
  • Sector
  • FGEN Health Care
  • GLBS Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • GLBS Nasdaq
  • Market Cap
  • FGEN 34.5M
  • GLBS 28.2M
  • IPO Year
  • FGEN 2014
  • GLBS 2007
  • Fundamental
  • Price
  • FGEN $0.57
  • GLBS $1.31
  • Analyst Decision
  • FGEN
  • GLBS
  • Analyst Count
  • FGEN 0
  • GLBS 0
  • Target Price
  • FGEN N/A
  • GLBS N/A
  • AVG Volume (30 Days)
  • FGEN 1.7M
  • GLBS 63.4K
  • Earning Date
  • FGEN 02-24-2025
  • GLBS 03-14-2025
  • Dividend Yield
  • FGEN N/A
  • GLBS N/A
  • EPS Growth
  • FGEN N/A
  • GLBS 61.29
  • EPS
  • FGEN N/A
  • GLBS 0.14
  • Revenue
  • FGEN $180,015,000.00
  • GLBS $33,289,000.00
  • Revenue This Year
  • FGEN $22.05
  • GLBS $15.39
  • Revenue Next Year
  • FGEN N/A
  • GLBS $43.34
  • P/E Ratio
  • FGEN N/A
  • GLBS $9.60
  • Revenue Growth
  • FGEN 16.15
  • GLBS 2.74
  • 52 Week Low
  • FGEN $0.18
  • GLBS $1.06
  • 52 Week High
  • FGEN $2.93
  • GLBS $2.42
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 57.36
  • GLBS 50.57
  • Support Level
  • FGEN $0.51
  • GLBS $1.26
  • Resistance Level
  • FGEN $0.76
  • GLBS $1.36
  • Average True Range (ATR)
  • FGEN 0.09
  • GLBS 0.08
  • MACD
  • FGEN -0.00
  • GLBS 0.02
  • Stochastic Oscillator
  • FGEN 33.26
  • GLBS 60.61

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

Share on Social Networks: